Physician

Internal Medicine

Dr. Azita Takeshian, MD


Azita Takeshian practices Internal Medicine. She attended University of Alabama Medical Center. University of Alabama Medical Center is ranked 37 in research and 17 in primary care medicine She received awards:"CMS Meaningful Use Stage 1 Certification". Doctor Azita Takeshian, MD is a published MD as well. She has 1 publication published. The latest was: Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia. She is registered with Medicare.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1518927532
NPPES Provider LastName   TAKESHIAN
NPPES Provider FirstName   AZITA
NPPES Provider ZIPCode   35235
NPPES Provider State   AL
Specialty Description   Nephrology
Total Claim Count   6728.0
Distinct Opioid Count   3.0
Opioid Claim Count   307.0
Percent Opioid Claims   4.56

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1518927532
Last Name Of The Provider TAKESHIAN
First Name Of The Provider AZITA
View All

Similar Doctors


Dr. Paul W. Sanders, MD
This Doctor is OpenDoctor Recommended.
Dr. Michael Allon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Rachel D. Labovitz, MD
This Doctor is OpenDoctor Recommended.
Dr. Lindsey N. Fogle, MD
This Doctor is OpenDoctor Recommended.
Dr. Jerry W. Jackson, MD
This Doctor is OpenDoctor Recommended.
Dr. Thomas S. Huddle, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Roslyn B. Mannon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Andrea L. Cherrington, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Rian L. Montgomery, MD
This Doctor is OpenDoctor Recommended.
Donald L. Quinn, PA
This Doctor is OpenDoctor Recommended.
Dr. Kimberly A. Coveney, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog